Akili to be delisted after getting acquired Before going public in 2022, digital therapeutics company Akili Inc. (Nasdaq: AKLI) raised $160 million in combined equity and debt financing.

Katika nchi zinazoendelea, mwanamke mmoja kati ya watano ambao wamejifungua hupata ugonjwa wa afya ya akili hasa sonona, kulingana na Shirika la Afya Ulimwenguni.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued ...

Akili will no longer pursue prescriptions for its digital therapeutics, instead switching entirely to over-the-counter, direct-to-consumer sales. Drift.com cuts over 30 Mass. workers in 2nd round ...

In September 2023, Akili eliminated 45 jobs after abadoning its prescription model. It also laid off 46 employees in January 2023. In 2023, the company posted a net loss of $59 million or 76 cents ...

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would ...